Africa: WHO Adds First Diagnostic Test for Ebola Bundibugyo Virus to Its Emergency Use Listing
The World Health Organization has granted Emergency Use Listing to the first molecular diagnostic test for the Bundibugyo Ebola virus. This move aims to accelerate the availability of reliable testing in low- and middle-income countries during outbreaks.
Why it matters
Rapid diagnostic capabilities are essential for containing viral outbreaks and reducing mortality rates in regions affected by Ebola.
Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL) . The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately.
The article provides a factual account of a WHO regulatory action and its intended public health impact.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in